Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Recs

0
Player Avatar Smiley81 (< 20) Submitted: 4/29/2008 10:56:48 AM : Outperform Start Price: $19.56 MRX Score: +90.46

$25+/share

Featured Broker Partners


Advertisement